Team:USTC CHINA

From 2013.igem.org

(Difference between revisions)
Line 159: Line 159:
   <div id="exp-text">
   <div id="exp-text">
   <span>Protein part</span><br />
   <span>Protein part</span><br />
-
   Before we achieve fresh expression, we use purified protein to obtain accurate data to verify our assumptions.<br />
+
   To achieve fresh expression ultimately, we used purified protein to obtain accurate data and verified assumptions.<br />
   <a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">more</a>
   <a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">more</a>
   </div>
   </div>
Line 168: Line 168:
   <div id="exp-text">
   <div id="exp-text">
   <span>Mice experiments</span><br />
   <span>Mice experiments</span><br />
-
   The most obvious character of our 2013USTC iGEM team is that we have not only achieved a series of molecule experiments but also tried mice experiments, which could be divided into transdermal experiments in vitro and animate mice experiments<br />
+
   The most prominent character of 2013USTC iGEM team is that we have not only achieved a series of molecule experiments but also tried mice experiments, including transdermal experiments in vitro and animate mice experiments<br />
   <a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results/FurthurWork">more</a>
   <a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results/FurthurWork">more</a>
   </div>
   </div>

Revision as of 00:37, 28 September 2013

USTC_China

In Situ Transdermal Vaccine

Fresh Expression, No Purification
Standardized, Block-based Design
Easy-transportation, Low Storage External Costs
Almost No Demand For Medical Conditions And Proferssionals

Project

Motivation

We hope to develop a fresh-expression transdermal vaccination.
We hope everyone in this world could equally enjoy the benefit of medical progress.
more

Design of Project

With the support of TD-1, a special polypeptide which can greatly facilitate macromolecule transdermal delivery through intact skin, we construct three different fuctional engineered bacillus subtilis; besides, we design a reporter system, including a kill switch, in the fouth type B.subtilis to improve usability and ensure biosafety.
ANTIGEN
As the core of our in-situ system,
TD1-antigen expresser is designed
and will share a great percentage of
the total bacteria in our "band-aid".
more
LTB
As one kind of our adjuvant expresser,
TD1-LTB is used to enhance the antigenicity.
For LTB has so many advantages, it's a wild using adjuvant for most of exsiting injected vaccine.
more
TNFα
TNFαis a chemotactic factor that recruits Langerhans Cells, antigen presenting cells beneath the skin barrier. The TNFα expresser is responsible for immigrating LC and triggering more intense immune responses.
more
REPORTER
Reporter notifies users whether the status of vaccine patch is all right and when they can stick the patches to arms . Further more killing switch is conveyed in them as a biosafety guard.
more

Experimental Measurement

Molecules part
We took E.coli and the PET vector as the positive control and realized our ideas in the B.subtilis expression system based on PHT43 shuttle vector.
more
Protein part
To achieve fresh expression ultimately, we used purified protein to obtain accurate data and verified assumptions.
more
Mice experiments
The most prominent character of 2013USTC iGEM team is that we have not only achieved a series of molecule experiments but also tried mice experiments, including transdermal experiments in vitro and animate mice experiments
more

Retrieved from "http://2013.igem.org/Team:USTC_CHINA"